These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 26885569)

  • 21. Comparative Safety and Tolerability of Prostacyclins in Pulmonary Hypertension.
    O'Connell C; Amar D; Boucly A; Savale L; Jaïs X; Chaumais MC; Montani D; Humbert M; Simonneau G; Sitbon O
    Drug Saf; 2016 Apr; 39(4):287-94. PubMed ID: 26748508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study.
    Kimura M; Tamura Y; Takei M; Yamamoto T; Ono T; Fujita J; Kataoka M; Kuwana M; Satoh T; Fukuda K
    BMC Pulm Med; 2015 May; 15():62. PubMed ID: 25971443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current treatment strategies for pulmonary arterial hypertension.
    Lee SH; Rubin LJ
    J Intern Med; 2005 Sep; 258(3):199-215. PubMed ID: 16115293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhaled Therapies for Pulmonary Hypertension.
    Hill NS; Preston IR; Roberts KE
    Respir Care; 2015 Jun; 60(6):794-802; discussion 802-5. PubMed ID: 26070575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary arterial hypertension : a comprehensive review of pharmacological treatment.
    Berman Rosenzweig E; Barst RJ
    Treat Respir Med; 2006; 5(2):117-27. PubMed ID: 16512692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evidence-based approach to the management of pulmonary arterial hypertension.
    Archer SL; Michelakis ED
    Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The current pharmacotherapy of pulmonary arterial hypertension].
    Betkier-Lipińska K; Ryczek R; Cwetsch A
    Pol Merkur Lekarski; 2015 Jan; 38(223):34-8. PubMed ID: 25763586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global research trends in the medical therapy of pulmonary arterial hypertension 2000-2014.
    Schreiber C; Edlinger C; Eder S; Ausserwinkler M; Wernly B; Pretsch I; Jung C; Hoppe UC; Lichtenauer M
    Pulm Pharmacol Ther; 2016 Aug; 39():21-7. PubMed ID: 27259806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on pulmonary arterial hypertension pharmacotherapy.
    Velayati A; Valerio MG; Shen M; Tariq S; Lanier GM; Aronow WS
    Postgrad Med; 2016 Jun; 128(5):460-73. PubMed ID: 27232660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of pulmonary arterial hypertension].
    Olschewski H; Ghofrani A; Enke B; Reichenberger F; Voswinckel R; Kreckel A; Ghofrani S; Wiedemann R; Schulz R; Grimminger F; Seeger W
    Internist (Berl); 2005 Mar; 46(3):341-9. PubMed ID: 15703889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Medical treatment of pulmonary hypertension: what's new?].
    Richter MJ; Gall H; Tello K; Sommer N; Seeger W; Grimminger F; Ghofrani HA
    Internist (Berl); 2015 May; 56(5):573-82. PubMed ID: 25924799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving Survival in Patients with Pulmonary Arterial Hypertension: Focus on Intravenous Epoprostenol.
    Demerouti E; Karyofyllis P; Manginas A; Anthi A; Karatasakis G; Athanassopoulos G; Voudris V
    Am J Cardiovasc Drugs; 2019 Apr; 19(2):99-105. PubMed ID: 30671881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging drugs for pulmonary hypertension.
    Girgis RE
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):71-85. PubMed ID: 20095920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary arterial hypertension: classification and therapy with a focus on prostaglandin analogs.
    Papierniak ES; Lowenthal DT; Mubarak K
    Am J Ther; 2012 Jul; 19(4):300-14. PubMed ID: 21642835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostacyclins and pulmonary arterial hypertension in children.
    Wu Y; Liu HM; Gu L; Li QW; Zhu L
    Eur Rev Med Pharmacol Sci; 2022 Jan; 26(1):37-45. PubMed ID: 35049017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The management of acute pulmonary arterial hypertension.
    Hui-li G
    Cardiovasc Ther; 2011 Jun; 29(3):153-75. PubMed ID: 20560976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical therapies for pulmonary arterial hypertension.
    Pulido T; Zayas N; de Mendieta MA; Plascencia K; Escobar J
    Heart Fail Rev; 2016 May; 21(3):273-83. PubMed ID: 26791159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Riociguat, an oral soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension.
    Belik J
    Curr Opin Investig Drugs; 2009 Sep; 10(9):971-9. PubMed ID: 19705340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current and advancing treatments for pulmonary arterial hypertension in childhood.
    Zijlstra WM; Ploegstra MJ; Berger RM
    Expert Rev Respir Med; 2014 Oct; 8(5):615-28. PubMed ID: 25047735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
    Hansmann G; Apitz C
    Heart; 2016 May; 102 Suppl 2():ii67-85. PubMed ID: 27053700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.